Abstract
Many abnormalities have been described in the brains of patients with Alzheimer’s disease (AD), particularly in tissue obtained at autopsy. AD patients usually die in late stages of the disease, although sometimes other illnesses or accidents lead to death in early AD. Abnormalities in autopsy brain can be the result of agonal and postmortem artifacts. A major issue has therefore been to try to decide which abnormalities in AD brain are primary and which are secondary to the disease or to the terminal state.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Selkoe, D.J.: Alzheimer’s disease is a synaptic failure. Science 2002; 298: 1789–1791.
Obrenovich, M.E. et al.: Amyloid-beta: a (life) preserver for the brain. Neurobiol Aging 2002; 23: 1097–1099.
Blass, J.P.: Alzheimer’s disease and Alzheimer’s dementia: distinct but overlapping entities. Neurobiol Aging 2002; 23: 1077–1084.
Craft, S. et al.: Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer’s disease differ according to apolipoprotein-E genotype. Ann NY Acad Sci 2000; 903: 222–228.
Manning, C.A.; Ragozzino, M.E.; Gold, P.E.: Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer’s type. Neurobiol Aging 1993; 14: 523–528.
Blass, J.P.: Metabolic enhancement for the treatment of Alzheimer disease. Res Practice Alz Dis Cognit Decline 2002; 6: 282–287.
Blass, J.P. et al.: A nutritional supplement in Alzheimer disease. Neurosci Abstr, in press.
Blass, J.P.: The mitochondrial spiral. An adequate cause of dementia in the Alzheimer’s syndrome. Ann NY Acad Sci 2000; 924: 170–183.
Gibson, G.E.: Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer’s disease. Free Radic Biol Med 2002; 32: 1061–1070.
Blass, J.P.; Sheu, R.K.; Gibson, G.E.: Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann NY Acad Sci 2000; 903: 204–221.
Mattson, M.P. et al.: Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann NY Acad Sci 1999; 893: 154–175.
Blass, J.P.; Gibson, G.E.; Hoyer, S.: The role of the metabolic lesion in Alzheimer’s disease. 7Alz Dis 2002; 4: 225–232.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Blass, J.P. (2004). Metabolism and Alzheimer’s Disease. In: Richter, R.W., Richter, B.Z. (eds) Alzheimer’s Disease. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-661-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-59259-661-4_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4485-9
Online ISBN: 978-1-59259-661-4
eBook Packages: Springer Book Archive